ARCHIVES

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990

Report Outlines “Grand Challenges” For Chemistry

March 7, 2003

CPSC Relies On NCI Findings For New Policy

July 21, 1978

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974